Pharmafile Logo
Pharmafocus logo
Advanced Search

R&D

Showing 15 posts of 140 posts found.

takeda_usa_pharmaceuticals_u

Takeda’s lung cancer treatment Alunbrig proves successful in Phase III trial

September 26, 2018
Research and Development Alunbrig, R&D, Takeda, phase III, research

Japanese pharma firm Takeda have announced that lung cancer treatment Alunbrig has proven successful in reducing the risk of disease …

News
sean-harper

Amgen announces resignation of two top executives

July 27, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, Anthony C Cooper, R&D, biotech, retire, sean harper

Amgen’s head of R&D, Dr Sean Harper, has announced that he is retiring from his current position as Executive Vice …

Appointment
shutterstock_138095450

AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide

October 24, 2017
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC

New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …

News
shutterstock_212432119

The pharmaceutical research and development challenge

June 30, 2017
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

This report from Kalorama Information was featured in the Spring 2017 edition of Pharmafile. Despite new approaches, new technologies and …

News
boardroom

Enhancing scientific acumen in the pharma boardroom

March 17, 2017
Medical Communications R&D

Dana M. Krueger and Neha Rajdev, of Russell Reynolds, discuss the importance of a scientific background in the boardrooms of …

News
jenny_tragner_-_main

Pharmaceutical R&D tax credit regulatory legislation: The need for clarity

January 20, 2017
Medical Communications, Research and Development, Sales and Marketing R&D, pharmafile

Since their introduction in the UK in 2000, R&D tax credits have provided a significant boost to pharmaceutical and biotech …

News
biogen_austria_238

New head of R&D at Biogen

April 27, 2016
Research and Development Biogen, Pfizer, R&D, erhlers, michael, michael erhlers, research and development

Biogen (NASDAQ: BIIB) has announced the appointment of Dr Michael Ehlers as executive vice president, research and development. His role …

Appointment
handshake

Allergan to partner with Heptares in Alzheimer’s disease collaboration

April 7, 2016
Manufacturing and Production, Research and Development, Sales and Marketing Allergan, Alzheimer's, Heptares, R&D, collaboration, commercialisation, h1, h4, neurological disorders, partnership, research and development, treatments

Bouncing back quickly from the collapse of the collapse of the Pfizer inversion deal, Allergan (NYSE:AGN) has announced a new …

News
World Cancer Day 2016

Cancer – dealing with the greatest health challenge of our time

February 4, 2016
Manufacturing and Production, Research and Development Cancer, IFPMA, R&D, World Cancer Day, collaboration, partnership

Cancer is one of the greatest health challenges of our time, and a leading cause of death in every corner …

Feature
Daiichi Sankyo researchers

Daiichi Sankyo to expand access to clinical trial data

February 3, 2016
Research and Development Daiichi Sankyo, R&D, clinical trials, open access, open data, transparency

Daiichi Sankyo has announced today that it will share clinical trial data to qualified researchers through an online web request …

News

Is bioscience still getting lost in translation?

January 27, 2016
Research and Development CASMI, Centre for Sustainable Medical Innovation, Professor Richard Barker, R&D, bioscience

After several years of anguish about pharmaceutical pipelines, R&D productivity seems to be picking up.New medicines and cell and gene …

Feature
Researcher and patient

Patient involvement ‘would improve medicines R&D’

January 15, 2016
Medical Communications, Research and Development EUPATI, Patient and Public Involvement, R&D

A new study has revealed a belief among pharma industry executives that greater involvement of patients and the public could …

News
Return on investment

Analysts say pharma R&D returns challenged by drag of high costs

December 16, 2015
Research and Development, Sales and Marketing R&D, drug development, research and development, return of investment, sales, sales forecasts

The projected rate of return on pharma industry research and development has more than halved since 2010, from 10.1% to …

News
clinical_trial-web

Pharma deals crucial to cutting R&D costs

December 16, 2015
Research and Development GlobalData, R&D, drug development, pharma, research and development

With the average cost of getting a novel drug to market at almost $2.5 billion, and few products achieving blockbuster …

News
Monopoly board tax

Pharma companies warned on patent box changes

December 16, 2015
Research and Development R&D, patent box, pharma, research and development, tax

Proposed Government changes to legislation will require businesses to track and trace all R&D expenditure if they want to continue …

News

Latest content

GSK shares data from global shingles survey

December 1, 2023

AbbVie to acquire ImmunoGen for approximately $10.1bn

December 1, 2023

FDA accepts NDA for Karuna’s schizophrenia treatment

November 30, 2023

Vivos Therapeutics gains FDA 510(k) clearance for sleep apnea treatment device

November 30, 2023

Tolremo doses first patient in phase 1 trial for drug to combat transcriptional cancer drug resistance

November 29, 2023